AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Debt / NOTE 2.000% 3/1
Market price (% of par)
92.46%
All holders as of 31 Dec 2025
Q4 2025
Total 13F principal
$337,272,006
Total reported market value
$312,110,942
Principal change
+$38,613,800
Market value change
+$35,882,119
Number of holders
41
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 31 Dec 2025, 41 institutional investors reported holding $337,272,006 in principal (par value) of AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1.

Institutional Holders of AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q4 $337,272,006 $312,110,942 +$35,882,119 92.46% 41
2025 Q3 $298,658,206 $271,682,316 +$15,400,429 90.9% 44
2025 Q2 $287,504,200 $250,404,674 -$1,633,019 86.66% 42
2025 Q1 $289,012,700 $257,820,283 -$20,287,313 88.89% 39
2024 Q4 $310,090,000 $290,929,251 -$11,267,553 93.11% 36
2024 Q3 $320,190,500 $339,259,650 +$336,118,248 105.6% 35